Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

Kathy Griffin — who previously had a battle with lung cancer — revealed that she a hysterectomy due to a precancerous ...

By integrating spirometry with low-dose CT scans, physicians at Philadelphia-based Temple University Health System are identifying serious lung conditions, such as chronic obstructive pulmonary ...

Early detection is the key to surviving lung cancer, but Oklahomans rank 44th out of 47 states in early-stage diagnosis ...

A man who lost six members of his family and his best friend to cancer has urged others to get tested after he received an ...

Lung cancer is by far the most lethal form of cancer in the U.S., accounting for about 1 in 5 of all cancer deaths.

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...

Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival ...